Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Glomerulus | 23 | 2023 | 29 | 1.960 |
Why?
|
| Podocytes | 10 | 2023 | 11 | 1.370 |
Why?
|
| Kidney Diseases | 4 | 2023 | 121 | 0.800 |
Why?
|
| Diabetic Nephropathies | 10 | 2021 | 56 | 0.590 |
Why?
|
| Animals | 28 | 2023 | 1875 | 0.560 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 4 | 2023 | 7 | 0.500 |
Why?
|
| Kidney | 4 | 2018 | 184 | 0.460 |
Why?
|
| Mice | 12 | 2023 | 746 | 0.430 |
Why?
|
| Lead Poisoning | 1 | 2013 | 5 | 0.410 |
Why?
|
| Cell Count | 5 | 2011 | 18 | 0.380 |
Why?
|
| Diabetes Mellitus, Type 1 | 6 | 2002 | 52 | 0.370 |
Why?
|
| Diabetes Mellitus, Experimental | 8 | 2021 | 29 | 0.350 |
Why?
|
| Microfilament Proteins | 2 | 2021 | 7 | 0.320 |
Why?
|
| Nephrotic Syndrome | 2 | 2021 | 5 | 0.230 |
Why?
|
| Kidney Tubules, Proximal | 2 | 2001 | 3 | 0.200 |
Why?
|
| Albuminuria | 3 | 2021 | 31 | 0.200 |
Why?
|
| Time Factors | 4 | 2013 | 321 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 2 | 2021 | 2 | 0.190 |
Why?
|
| Female | 11 | 2021 | 4060 | 0.190 |
Why?
|
| Rats | 13 | 2017 | 571 | 0.190 |
Why?
|
| Humans | 17 | 2023 | 6794 | 0.180 |
Why?
|
| Proteinuria | 4 | 2017 | 15 | 0.180 |
Why?
|
| Adenylate Kinase | 1 | 2021 | 4 | 0.180 |
Why?
|
| Histones | 1 | 2021 | 13 | 0.170 |
Why?
|
| Eye Proteins | 1 | 2021 | 10 | 0.170 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 38 | 0.170 |
Why?
|
| Pathology | 1 | 2001 | 3 | 0.170 |
Why?
|
| Male | 15 | 2021 | 3671 | 0.160 |
Why?
|
| Hypertrophy | 2 | 2021 | 6 | 0.150 |
Why?
|
| Membrane Proteins | 1 | 2018 | 48 | 0.140 |
Why?
|
| TRPC Cation Channels | 1 | 2017 | 1 | 0.140 |
Why?
|
| Indazoles | 1 | 2017 | 3 | 0.140 |
Why?
|
| Hypertension, Renal | 1 | 2017 | 4 | 0.140 |
Why?
|
| Mice, Knockout | 4 | 2021 | 150 | 0.130 |
Why?
|
| Kidney Transplantation | 1 | 2018 | 101 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 2 | 2018 | 258 | 0.130 |
Why?
|
| Capillaries | 3 | 2013 | 11 | 0.120 |
Why?
|
| Nephrectomy | 4 | 2023 | 14 | 0.120 |
Why?
|
| Adipose Tissue, Brown | 1 | 2015 | 16 | 0.120 |
Why?
|
| Longevity | 1 | 2015 | 7 | 0.120 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 25 | 0.110 |
Why?
|
| Phosphoproteins | 1 | 2015 | 9 | 0.110 |
Why?
|
| Gene Deletion | 1 | 2015 | 17 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 19 | 0.110 |
Why?
|
| Disease Progression | 4 | 2023 | 170 | 0.110 |
Why?
|
| Renal Insufficiency | 1 | 2015 | 21 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2010 | 282 | 0.110 |
Why?
|
| Age Factors | 2 | 2013 | 193 | 0.110 |
Why?
|
| Biomarkers | 1 | 2015 | 214 | 0.110 |
Why?
|
| Adolescent | 7 | 2021 | 869 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1994 | 64 | 0.100 |
Why?
|
| Mesangial Cells | 1 | 2013 | 1 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 170 | 0.100 |
Why?
|
| Adult | 9 | 2021 | 2113 | 0.100 |
Why?
|
| Thiazoles | 2 | 2006 | 3 | 0.090 |
Why?
|
| Child | 5 | 2021 | 524 | 0.090 |
Why?
|
| Glomerular Mesangium | 3 | 2003 | 4 | 0.090 |
Why?
|
| Antigens | 2 | 1989 | 3 | 0.090 |
Why?
|
| Glycation End Products, Advanced | 4 | 2006 | 7 | 0.090 |
Why?
|
| Middle Aged | 7 | 2021 | 2108 | 0.090 |
Why?
|
| Basement Membrane | 8 | 2003 | 11 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 2 | 2021 | 9 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 1 | 2015 | 420 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2023 | 246 | 0.080 |
Why?
|
| Up-Regulation | 2 | 2023 | 94 | 0.080 |
Why?
|
| Child, Preschool | 2 | 2021 | 258 | 0.080 |
Why?
|
| Aged | 5 | 2021 | 1539 | 0.080 |
Why?
|
| Young Adult | 2 | 2021 | 567 | 0.070 |
Why?
|
| Models, Theoretical | 1 | 2006 | 15 | 0.060 |
Why?
|
| Biopsy | 4 | 2003 | 36 | 0.060 |
Why?
|
| Kidney Cortex | 2 | 2002 | 2 | 0.060 |
Why?
|
| Vasoconstrictor Agents | 1 | 2004 | 5 | 0.060 |
Why?
|
| Angiotensin II | 1 | 2004 | 18 | 0.060 |
Why?
|
| Puromycin | 1 | 1984 | 1 | 0.060 |
Why?
|
| Puromycin Aminonucleoside | 1 | 1984 | 1 | 0.060 |
Why?
|
| Glomerular Filtration Rate | 3 | 2018 | 115 | 0.050 |
Why?
|
| Artifacts | 1 | 2023 | 5 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2023 | 11 | 0.050 |
Why?
|
| Microscopy, Electron | 5 | 2003 | 21 | 0.050 |
Why?
|
| Hypertension | 1 | 2004 | 147 | 0.050 |
Why?
|
| Models, Anatomic | 1 | 2002 | 8 | 0.050 |
Why?
|
| Pyridoxamine | 1 | 2002 | 1 | 0.050 |
Why?
|
| Hyperlipidemias | 1 | 2002 | 22 | 0.050 |
Why?
|
| Nephrosis, Lipoid | 1 | 2021 | 1 | 0.040 |
Why?
|
| Glomerulonephritis, Membranous | 1 | 2021 | 2 | 0.040 |
Why?
|
| Cell Size | 1 | 2021 | 3 | 0.040 |
Why?
|
| Cell Survival | 1 | 2021 | 33 | 0.040 |
Why?
|
| Infant | 1 | 2021 | 187 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2001 | 6 | 0.040 |
Why?
|
| Guanidines | 2 | 2002 | 3 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 169 | 0.040 |
Why?
|
| Staining and Labeling | 2 | 2011 | 10 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2011 | 118 | 0.040 |
Why?
|
| Actin Cytoskeleton | 1 | 2018 | 1 | 0.040 |
Why?
|
| src Homology Domains | 1 | 2018 | 1 | 0.040 |
Why?
|
| Homozygote | 1 | 2018 | 2 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2018 | 8 | 0.040 |
Why?
|
| Mice, 129 Strain | 1 | 2018 | 5 | 0.040 |
Why?
|
| Allografts | 1 | 2018 | 7 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 13 | 0.040 |
Why?
|
| Rats, Inbred Strains | 3 | 1989 | 49 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 26 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2018 | 73 | 0.040 |
Why?
|
| Rats, Inbred Dahl | 1 | 2017 | 2 | 0.030 |
Why?
|
| Rats, Transgenic | 1 | 2017 | 2 | 0.030 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2017 | 2 | 0.030 |
Why?
|
| Small Molecule Libraries | 1 | 2017 | 2 | 0.030 |
Why?
|
| Reference Values | 3 | 2002 | 56 | 0.030 |
Why?
|
| Mutation | 1 | 2017 | 97 | 0.030 |
Why?
|
| Islets of Langerhans Transplantation | 3 | 1982 | 4 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 231 | 0.030 |
Why?
|
| Aging | 2 | 1996 | 105 | 0.030 |
Why?
|
| Glucose | 1 | 1996 | 50 | 0.030 |
Why?
|
| Immunoglobulin G | 3 | 1996 | 19 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 1996 | 53 | 0.030 |
Why?
|
| Dogs | 2 | 1994 | 18 | 0.030 |
Why?
|
| Myocardium | 1 | 1996 | 25 | 0.030 |
Why?
|
| Heart | 1 | 1996 | 25 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1996 | 31 | 0.030 |
Why?
|
| Uncoupling Protein 1 | 1 | 2015 | 12 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2015 | 18 | 0.030 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 15 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2015 | 11 | 0.030 |
Why?
|
| Ion Channels | 1 | 2015 | 14 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2015 | 17 | 0.030 |
Why?
|
| Neoplastic Stem Cells | 1 | 2015 | 24 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2015 | 22 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 120 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 156 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2015 | 53 | 0.030 |
Why?
|
| Diabetes Mellitus | 3 | 2002 | 208 | 0.030 |
Why?
|
| Collagen | 3 | 2002 | 31 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 3 | 1989 | 24 | 0.030 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 293 | 0.030 |
Why?
|
| Epithelium | 2 | 1984 | 22 | 0.020 |
Why?
|
| Microtomy | 1 | 2011 | 2 | 0.020 |
Why?
|
| Scintillation Counting | 1 | 1989 | 1 | 0.020 |
Why?
|
| Fluoresceins | 1 | 1989 | 2 | 0.020 |
Why?
|
| Fluorescein | 1 | 1989 | 6 | 0.020 |
Why?
|
| Organ Size | 2 | 2002 | 31 | 0.020 |
Why?
|
| Antibodies | 1 | 1989 | 16 | 0.020 |
Why?
|
| Image Enhancement | 1 | 1989 | 6 | 0.020 |
Why?
|
| Creatinine | 2 | 2002 | 48 | 0.020 |
Why?
|
| Streptozocin | 2 | 2004 | 11 | 0.020 |
Why?
|
| Lysine | 1 | 2006 | 3 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 10 | 0.020 |
Why?
|
| Immunoassay | 1 | 1984 | 8 | 0.010 |
Why?
|
| Dog Diseases | 1 | 1984 | 2 | 0.010 |
Why?
|
| Cadaver | 1 | 2003 | 12 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2003 | 285 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2002 | 19 | 0.010 |
Why?
|
| Fibrosis | 1 | 2002 | 53 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2002 | 33 | 0.010 |
Why?
|
| Urine | 1 | 2001 | 14 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 1998 | 108 | 0.010 |
Why?
|
| Rats, Inbred Lew | 3 | 1982 | 4 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 1996 | 1 | 0.010 |
Why?
|
| Amyloid beta-Peptides | 1 | 1996 | 5 | 0.010 |
Why?
|
| Nitroglycerin | 1 | 1996 | 2 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1996 | 4 | 0.010 |
Why?
|
| Vasodilation | 1 | 1996 | 5 | 0.010 |
Why?
|
| Species Specificity | 1 | 1996 | 17 | 0.010 |
Why?
|
| Cardiomegaly | 1 | 1996 | 4 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 1996 | 27 | 0.010 |
Why?
|
| Aorta | 1 | 1996 | 20 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1996 | 50 | 0.010 |
Why?
|
| Muscle Development | 1 | 1996 | 19 | 0.010 |
Why?
|
| Transplantation, Homologous | 3 | 1980 | 16 | 0.010 |
Why?
|
| Body Weight | 1 | 1996 | 90 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1996 | 112 | 0.010 |
Why?
|
| Histological Techniques | 1 | 1987 | 2 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1987 | 15 | 0.000 |
Why?
|
| Complement C3 | 1 | 1982 | 1 | 0.000 |
Why?
|
| Sex Factors | 1 | 1983 | 155 | 0.000 |
Why?
|
| Actomyosin | 1 | 1982 | 1 | 0.000 |
Why?
|
| Detergents | 1 | 1982 | 1 | 0.000 |
Why?
|
| Laminin | 1 | 1982 | 5 | 0.000 |
Why?
|
| Amyloid | 1 | 1982 | 3 | 0.000 |
Why?
|
| Glycoproteins | 1 | 1982 | 10 | 0.000 |
Why?
|
| Fibronectins | 1 | 1982 | 18 | 0.000 |
Why?
|
| Pancreas Transplantation | 1 | 1980 | 3 | 0.000 |
Why?
|
| Animals, Newborn | 1 | 1980 | 112 | 0.000 |
Why?
|
| Insulin | 1 | 1979 | 146 | 0.000 |
Why?
|
| Blood Glucose | 1 | 1979 | 188 | 0.000 |
Why?
|